Delivra Topical Creatine Combined With Oral Creatine for Improving Muscular Power

NCT03006861 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2018-06-28

No results posted yet for this study

Summary

Creatine is a nutritional supplement that is often ingested to improve exercise performance. The advent of a new product that is applied to the skin overlying muscle offers potential benefit, if the creatine can be targeted to specific muscles. The investigators are testing a novel creatine cream to determine the effects on human muscular performance. The investigators are assessing whether 7 days of topical creatine application is additive to orally-ingested creatine for improving muscular power (determined by knee extension).

Conditions

  • Muscle Weakness

Interventions

DIETARY_SUPPLEMENT

3.5 mL/d topical creatine

DIETARY_SUPPLEMENT

3.5 mL/d topical placebo

DIETARY_SUPPLEMENT

21 g/d Oral creatine

DIETARY_SUPPLEMENT

21 g/d oral placebo

Sponsors & Collaborators

  • University of Guelph

    collaborator OTHER
  • University of Prince Edward Island

    collaborator OTHER
  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Philip Chilibeck, PhD · University of Saskatchewan

  • Jamie Burr, PhD · University of Guelph

  • Travis Saunders, PhD · University of Prince Edward Island

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-05-31
Completion
2017-10-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03006861 on ClinicalTrials.gov